Request Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-11186
Strong government initiative to contain Covid-19 in favor of selling cartridges for RT-PCR automated systems
In the current scenario, the demand for cartridges for automated RT-PCR systems is growing significantly as the Centers for Disease Control and Prevention (CDC) distribute PCR test kits to multiple cities. In addition to accelerating the validation process, the CDC is providing: Public health laboratories with diagnostic tools before unapproved commercial products and test kits are available on a large scale. This in turn serves as a catalyst for the growth of cartridges for the RT-PCR automated systems market.
It should be noted that the sudden spike in demand is creating a shortage of swaps and reagents for sample collection kits and diagnostic tools, and is emerging as one of the obstacles to the ability of public health agencies to conduct extensive testing. In turn, many health startups have started releasing home sampling kits and cartridge-based test kits, and a lack of approval from the Food and Drug Administration has halted sales of these products.
North American market will take the lead as US races to step up Covid-19 testing
North America is expected to maintain its leading position in the real-time PCR system market and the cartridge market for RT-PCR automated systems. The rise of the United States as the region most impacted by the COVID-19 pandemic is currently playing a significant role in market growth, accelerating further due to increased test kit production and the presence of advanced healthcare systems. Many market participants are also launching innovative Covid-19 detection kits using proven PCR-based technology.
In March 2020, Cepheid’s Xpert® Xpress SARS-CoV-2 received FDA Emergency Use Authorization (EUC) for point-of-care Covid-19 diagnosis. Automated molecular testing can quickly detect current pandemics in about 45 minutes, with less than a minute required for sample preparation. It is performed on a GeneXpert instrument system using disposable cartridges with sample processing control (SPC) and probe testing control (PCC). Cartridge sales for RT-PCR automated systems are expected to grow strongly going forward as the FDA accelerates reviews and approvals for new diagnostics during the coronavirus pandemic.
Cartridges for RT-PCR Automated Systems Market – Competitive Landscape
In a separate section, the report covers the competitive scenario of Cartridges for RT-PCR Automated Systems market which offers in-depth profiling of key market players with new product launches, total revenue, regional footprint, and growth strategies detailed. Notable vendors include Thermo Fisher Scientific, Fluidigm Corporation, QIAGEN, Danaher Corporation, Agilent Technologies, Hoffmann-La Roche AG, GE Healthcare, and Bio-Rad Laboratories Inc. and Abbott Laboratories.
Due to the rapid spread of coronavirus in multiple countries and the FDA’s EUA for Cepheid’s Xpert® Xpress SARS-CoV-2, more and more companies are racing to launch effective products and contribute to stopping the spread of Covid-19. .
- March 2020, Convergent Technologies GmbH & Co. KG announced the availability of the Convergys® POC RT-PCR Covid-19 Detection Kit for use with the cartridge-based standalone Convergys® POC RT-PCR Nucleic Acid Detection System. The company is also working closely with the Ukrainian Ministry of Health to fight Covid-19.
- In February 2019, Singapore-based company Vela Diagnostics announced the development of a new diagnostic test for the detection of Covid-19 – ViroKey ™ SARS-CoV-2 RT-PCR test, which has been submitted to the FDA for EUA approval. . The company is also co-developing with Great Basin Scientific a Covid-19 assay for use in the latter sample-to-result diagnostic system using disposable cartridges with fully integrated reagents and internal controls.
Customization Request@
https://www.futuremarketinsights.com/customization-available/rep-gb-11186
This report segments the Cartridges for RT-PCR Automated Systems Market into 4 segments based on sample type, application, end user, and region.
Cartridges for RT-PCR Automated Systems Market Analysis by Sample Type
- all-in-one
- reversed phase cartridge
- Prefilled Buffer Cartridge System
- Blood Genomic DNA Kit Cartridge System
- Tissue Genomic DNA Kit Cartridge System
- Tissue Total RNA Kit Cartridge System
- Viral DNA/RNA Kit Cartridge System
- Gel Extraction Kit Cartridge System
Cartridges for RT-PCR Automated Systems Market Analysis by Application
- blood test
- tumor examination
- pathogen test
- research and development
- forensics
Cartridges for RT-PCR Automated Systems Market Analysis by End User
- clinical research institute
- The lab
- public health institute
- diagnostic center
- hospital
- educational institution
Regional Analysis of Cartridges for RT-PCR Automated Systems Market
- North America
- Western Europe
- Latin America
- Eastern Europe
- Japan
- Asia Pacific excluding Japan (APEJ)
- Middle East and Africa (MEA)
Request Reporting Methodology @
https://www.futuremarketinsights.com/askus/rep-gb-11186
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs